Cleared Traditional

HYSTEROMED 100 (K930912) - FDA 510(k) Clearance

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K930912 · Northgate Technologies, Inc. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1994
Decision
602d
Days
Class 2
Risk

K930912 is an FDA 510(k) clearance for the HYSTEROMED 100. Classified as Insufflator, Hysteroscopic (product code HIG), Class II - Special Controls.

Submitted by Northgate Technologies, Inc. (Arlington Heights, US). The FDA issued a Cleared decision on October 17, 1994 after a review of 602 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.1700 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Obstetrics & Gynecology submissions.

View all Northgate Technologies, Inc. devices

Submission Details

510(k) Number K930912 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 22, 1993
Decision Date October 17, 1994
Days to Decision 602 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
442d slower than avg
Panel avg: 160d · This submission: 602d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HIG Insufflator, Hysteroscopic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.1700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - HIG Insufflator, Hysteroscopic

All 55
Devices cleared under the same product code (HIG) and FDA review panel - the closest regulatory comparables to K930912.
Asurys Fluid Management System
K251273 · Boston Scientific Corporation · Mar 2026
Fluent Pro Fluid Management System (FLT-200)
K240886 · Hologic, Inc. · Jul 2024
X-FLO Fluid Management System
K210628 · Thermedx, LLC · Nov 2021
Endomat Select, IBS Shaver Software, License
K201355 · Karl Storz SE & CO. KG · Jul 2020
Endomat Select
K180735 · Karl Storz SE & CO. KG · Oct 2018
Fluent Fluid Management System
K180825 · Hologic, Inc. · Aug 2018